|
Zinc Finger Recombinases for Endogenous Genome Tailoring
|
5R21CA126664-02
|
$251,641
|
$125,821
|
BARBAS, CARLOS
|
SCRIPPS RESEARCH INSTITUTE
|
|
X-ray Targeted Therapeutic Genes within Nanoparticles
|
5R01CA125757-03
|
$46,580
|
$46,580
|
Hallahan, Dennis
|
VANDERBILT UNIVERSITY
|
|
X-ray Targeted Therapeutic Genes within Nanoparticles
|
7R01CA125757-04
|
$320,505
|
$320,505
|
Hallahan, Dennis
|
WASHINGTON UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-09
|
$1,961,166
|
$353,010
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Virotherapy for Relapsed Refractory Multiple Myeloma
|
5R01CA125614-04
|
$245,693
|
$122,847
|
DISPENZIERI, ANGELA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
|
5R01CA079218-10
|
$328,425
|
$65,685
|
Gill, Parkash
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-05
|
$114,400
|
$28,600
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-05
|
$2,180,817
|
$545,204
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USING VIRAL NANOPARTICLES TO TARGET CANCER
|
5R01CA112075-05
|
$767,912
|
$383,956
|
MANCHESTER, MARIANNE
|
SCRIPPS RESEARCH INSTITUTE
|
|
University of Texas SPORE in Lung Cancer
|
5P50CA070907-12
|
$2,300,000
|
$460,000
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-09S1
|
$57,442
|
$22,977
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-10S1
|
$141,526
|
$56,610
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-10
|
$2,001,032
|
$800,413
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
3P50CA100632-07S1
|
$52,857
|
$4,229
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-07
|
$2,300,000
|
$184,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Universal MUC1 Targeted Immunotherapy
|
1R43CA141738-01
|
$140,720
|
$140,720
|
ORENTAS, RIMAS
|
LENTIGEN CORPORATION
|
|
Understanding and Eliminating Oncogenic EGFR Signaling in Malignant Glioma
|
1U01CA141556-01
|
$677,676
|
$169,419
|
CHAREST, ALAIN
|
TUFTS MEDICAL CENTER
|
|
Ultrasound-guided gene delivery in pancreatic cancer
|
1R03CA140024-01
|
$70,542
|
$70,542
|
Claudio, Pier Paolo
|
MARSHALL UNIVERSITY
|
|
Ultrasound guided site-specific gene delivery in prostate cancer
|
1R21CA131395-01A2
|
$184,800
|
$184,800
|
Claudio, Pier Paolo
|
MARSHALL UNIVERSITY
|
|
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
|
5R01CA118085-04
|
$290,571
|
$72,643
|
ZHOU, PENGBO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Tumor-Targeting Oligonucleotides
|
5R01CA122383-04
|
$255,082
|
$63,771
|
BATES, PAULA
|
UNIVERSITY OF LOUISVILLE
|
|
Tumor-targeted silencing of Bcl-2/Bcl-xL by the self-assembled siRNA-nanovectors
|
5R01CA121830-04
|
$258,587
|
$258,587
|
Xu, Liang
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells
|
ZIA BC 011228
|
$215,584
|
$215,584
|
Yang, James
|
CCR (NCI)
|
|
Tumor Sensitization to Purine Analogs by E. coli PNP
|
5R01CA119170-04
|
$335,274
|
$335,274
|
SORSCHER, Eric
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor Immunology Institutional Training Grant
|
5T32CA009120-34
|
$383,014
|
$76,603
|
Dubinett, Steven
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Tumor Hypoxia Imaging - Laboratory and Clinical Studies
|
5P01CA115675-04
|
$1,907,650
|
$247,995
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tumor exosomes as agents of genetic change
|
1R01CA141150-01
|
$293,682
|
$293,682
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor
|
5R01CA116322-03
|
$292,600
|
$292,600
|
JI, LIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Transposon Mediated Gene Therapy for Colorectal Cancer
|
5R01CA120383-03
|
$297,109
|
$297,109
|
McIvor, R
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
|
2R01CA098706-06A1
|
$286,978
|
$71,745
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-07
|
$263,406
|
$65,852
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-05
|
$1,353,467
|
$676,734
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Transgenic in vivo delivery of MDA7/IL24 for maligannt glioma therapy
|
5R01CA129489-02
|
$351,713
|
$351,713
|
GERMANO, ISABELLE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Transduction of T-cells to improve migration to tumor
|
5R01CA116206-05
|
$282,772
|
$197,940
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Training Program in Molecular Oncology and Immunology
|
5T32CA009161-35
|
$772,236
|
$77,224
|
PELLICER, ANGEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training Program in Free Radical and Radiation Biology
|
5T32CA078586-10
|
$221,472
|
$22,147
|
Spitz, Douglas
|
UNIVERSITY OF IOWA
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-25
|
$638,492
|
$638,492
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
TRAINING GRANT IN VIRAL AND CHEMICAL CARCINOGENESIS
|
5T32CA009320-25
|
$269,410
|
$202,058
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Training Grant in Cancer Biology
|
5T32CA009126-32
|
$307,515
|
$101,480
|
MAY, W.
|
UNIVERSITY OF FLORIDA
|
|
TRAIL-expressing Recombinant Adenovirus Based Immunotherapy for RCC
|
2R01CA109446-06A1
|
$268,794
|
$268,794
|
Griffith, Thomas
|
UNIVERSITY OF IOWA
|
|
Toward a transcription therapy for breast cancer
|
5R01CA113682-04
|
$268,871
|
$268,871
|
MUYAN, MESUT
|
UNIVERSITY OF ROCHESTER
|
|
Therapeutic VEGFR-2 Silencing via Targeted Nanoparticles
|
5F32CA132546-03
|
$53,354
|
$53,354
|
Greene, Rachel
|
EAST TENNESSEE STATE UNIVERSITY
|
|
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
|
7R01CA122518-02
|
$334,194
|
$334,194
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-10
|
$1,884,833
|
$471,208
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
THE THERAPY OF AML
|
5P01CA055164-17
|
$2,440,745
|
$122,037
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Roles of HBXAP Gene in Ovarian Cancer
|
5R01CA129080-02
|
$340,300
|
$85,075
|
SHIH, IE-MING
|
JOHNS HOPKINS UNIVERSITY
|
|
The Role of Fbxw7 in genetic instability and cancer
|
5R01CA116481-03
|
$355,982
|
$124,594
|
Mao, Jian-Hua
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
The Regulation of UPA and UPAR in Human Carcinoma Cells
|
5R01CA093926-08
|
$232,554
|
$58,139
|
HUANG, SHUANG
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
The Development of the Domestic Cat, Felis catus, as an Animal Model for Genetic
|
ZIA BC 005385
|
$366,517
|
$183,258
|
O'Brien, Stephen
|
CCR (NCI)
|
|
TGF-Beta Suppression and Promotion of Mammary Carcinomas
|
5R01CA085492-09
|
$454,641
|
$150,032
|
MOSES, HAROLD
|
VANDERBILT UNIVERSITY
|
Total relevant funding to Gene Therapy for this search: $68,363,970
|